123 related articles for article (PubMed ID: 22023895)
1. Emerging therapies for osteoporosis.
Deal C
Rheum Dis Clin North Am; 2011 Aug; 37(3):337-50, v. PubMed ID: 22023895
[TBL] [Abstract][Full Text] [Related]
2. Future therapeutic targets in osteoporosis.
Deal C
Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapeutic targets for osteoporosis treatment.
Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
[TBL] [Abstract][Full Text] [Related]
4. High-throughput in vivo screening for bone anabolic compounds with zebrafish.
Fleming A; Sato M; Goldsmith P
J Biomol Screen; 2005 Dec; 10(8):823-31. PubMed ID: 16234346
[TBL] [Abstract][Full Text] [Related]
5. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
[TBL] [Abstract][Full Text] [Related]
6. Potential new drug targets for osteoporosis.
Deal C
Nat Clin Pract Rheumatol; 2009 Jan; 5(1):20-7. PubMed ID: 19098925
[TBL] [Abstract][Full Text] [Related]
7. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
Sone T
Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging therapies for osteoporosis.
Mitchner NA; Harris ST
J Fam Pract; 2009 Jul; 58(7 Suppl Osteoporosis):S45-9. PubMed ID: 19825319
[TBL] [Abstract][Full Text] [Related]
9. [Advances treatment of osteoporosis: new molecules, new strategies].
Orcel P
Bull Acad Natl Med; 2010 Nov; 194(8):1505-16; discussion 1516-8. PubMed ID: 22046713
[TBL] [Abstract][Full Text] [Related]
10. Sequential therapy in the treatment of osteoporosis.
Boonen S; Milisen K; Gielen E; Vanderschueren D
Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
Marie PJ
Mol Interv; 2010 Oct; 10(5):305-12. PubMed ID: 21045244
[TBL] [Abstract][Full Text] [Related]
12. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.
Estell EG; Rosen CJ
Nat Rev Endocrinol; 2021 Jan; 17(1):31-46. PubMed ID: 33149262
[TBL] [Abstract][Full Text] [Related]
13. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
14. [New targets for treatment of osteoporosis].
Jakob F
Dtsch Med Wochenschr; 2011 Apr; 136(17):898-903. PubMed ID: 21523643
[No Abstract] [Full Text] [Related]
15. Simulating pharmaceutical treatment effects on osteoporosis via a bone remodeling algorithm targeting hypermineralized sites.
Jean-Louis M; Claudia CY; Jean-Marie R; Patrick C
Med Eng Phys; 2020 Feb; 76():56-68. PubMed ID: 31870544
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Treatment of Bone Loss.
Pang R; Xia W
Curr Pharm Des; 2017; 23(41):6298-6301. PubMed ID: 28521692
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of immobilization osteoporosis].
Inoue D
Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
[No Abstract] [Full Text] [Related]
18. Investigational anabolic therapies for osteoporosis.
Trivedi R; Goswami R; Chattopadhyay N
Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
[TBL] [Abstract][Full Text] [Related]
19. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
Saito M
Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
[TBL] [Abstract][Full Text] [Related]
20. Targeting sclerostin as potential treatment of osteoporosis.
Papapoulos SE
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
